Here, we provide first evidence that HCV genotype 1 infected carriers of a DR4 626C allele in combination with the DR4 683AA genotype have an increased risk for HCC indicating that TRAIL and its receptors contribute importantly to control of HCV infection and tumour surveillance by the immune system. Here, TNFSF10 is linked to neoplasm.